Agenus to participate at jefferies healthcare conference

Lexington, mass., may 25, 2022 (globe newswire) -- agenus (nasdaq: agen), an immuno-oncology company with an extensive pipeline of therapeutics designed to activate the immune response to cancers and infections, today announced that dr. garo armen, chairman and ceo of agenus and dr. steven o'day, chief medical officer, will participate in a fireside chat at the jefferies healthcare conference on thursday, june 9, 2022, at 11:30 am est. the conference will be held at the new york marriott marquis from june 8th – 10th, during which agenus will host one-on-one meetings with investors.
AGEN Ratings Summary
AGEN Quant Ranking